A Dose Titration Study of CPC-201 in Patients With Dementia of Alzheimer's Type
Public ClinicalTrials.gov record NCT02549196. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Dose Titration Study of CPC-201 in Patients With Dementia of Alzheimer's Type
Study identification
- NCT ID
- NCT02549196
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Chase Pharmaceuticals Corporation, an affiliate of Allergan plc
- Industry
- Enrollment
- 28 participants
Conditions and interventions
Conditions
Interventions
- Donepezil Drug
- Solifenacin Drug
Drug
Eligibility (public fields only)
- Age range
- 50 Years to 89 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 6, 2015
- Primary completion
- Sep 27, 2017
- Completion
- Sep 27, 2017
- Last update posted
- Mar 4, 2019
2015 – 2017
United States locations
- U.S. sites
- 4
- U.S. states
- 2
- U.S. cities
- 4
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Quantum Laboratories | Deerfield Beach | Florida | 33064 | — |
| Miami Jewish Health Systems | Miami | Florida | 33137 | — |
| Premiere Research Institute | West Palm Beach | Florida | 33407 | — |
| PMG Research | Winston-Salem | North Carolina | 27103 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02549196, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 4, 2019 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02549196 live on ClinicalTrials.gov.